JCR Pharmaceuticals Co.,Ltd.【JP:4552】Cash flow
Market cap
¥91.7B
P/E ratio
29.2x
| 2015/03 | 2016/03 | 2017/03 | 2018/03 | 2019/03 | 2020/03 | 2021/03 | 2022/03 | 2023/03 | 2024/03 | 2025/03 | |
| Depreciation & amortization | 1,352 | 1,408 | 1,448 | 1,382 | 1,343 | 1,434 | 1,892 | 1,945 | 1,997 | 3,197 | 3,374 |
| Cash from operations | 499 | 2,202 | 2,651 | 3,133 | 3,905 | 4,927 | 10,341 | 9,289 | -5,500 | 9,312 | -5,486 |
| Capital expenditures | -1,278 | -1,414 | -1,551 | -922 | -895 | -4,838 | -4,780 | -11,333 | -7,654 | -1,526 | -9,888 |
| Cash from investing | -1,420 | -981 | -841 | -1,587 | 240 | -4,161 | -3,290 | -3,250 | -15,002 | -2,690 | -9,874 |
| Payments for dividends | -592 | -640 | -699 | -748 | -834 | -989 | -1,083 | -2,169 | -2,739 | -2,500 | -2,505 |
| Repurchases of common stock | - | - | - | - | - | - | - | - | - | - | -2,530 |
| Proceeds from issuance of term debt, net | 200 | 500 | 2,300 | 200 | 200 | 3,050 | 1,250 | 750 | 4,750 | 9,600 | 750 |
| Repayments of term debt | -665 | -759 | -550 | -233 | -413 | -850 | -650 | -750 | -3,050 | -1,700 | -750 |
| Cash from financing | -1,261 | -1,314 | 146 | -2,175 | -917 | 2,048 | 8,304 | -2,179 | 1,948 | -2,031 | 9,736 |